Sally Furniss
Well-known member
Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells
<nobr>Shin Murakami,</nobr> <nobr>Taisuke Horimoto<sup>*</sup>,</nobr> <nobr>Le Quynh Mai,</nobr> <nobr>Chairul A. Nidom,</nobr> <nobr>Hualan Chen,</nobr> <nobr>Yukiko Muramoto,</nobr> <nobr>Shinya Yamada,</nobr> <nobr>Ayaka Iwasa,</nobr> <nobr>Kiyoko Iwatsuki-Horimoto,</nobr> <nobr>Masayuki Shimojima,</nobr> <nobr>Akira Iwata,</nobr> and <nobr>Yoshihiro Kawaoka<sup>*
</sup></nobr> Division of Virology, Department of Microbiology and Immunology, and International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama, Japan; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam, Avian Influenza Laboratory, Tropical Disease Centre, Airlangga University, Surabaya, Indonesia; Animal Influenza Laboratory of the Ministry of Agriculture and National Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, People's Republic of China; Nippon Institute for Biological Science, Tokyo, Japan; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin
[SIZE=-1] <sup>*</sup> To whom correspondence should be addressed. Email: horimoto@ims.u-tokyo.ac.jp<script type="text/javascript"><!-- var u = "horimoto", d = "ims.u-tokyo.ac.jp"; document.getElementById("em0").innerHTML = '<a href="mailto:' + u + '@' + d + '">' + u + '@' + d + '<\/a>'//--></script>. kawaoka@ims.u-tokyo.ac.jp<script type="text/javascript"><!-- var u = "kawaoka", d = "ims.u-tokyo.ac.jp"; document.getElementById("em1").innerHTML = '<a href="mailto:' + u + '@' + d + '">' + u + '@' + d + '<\/a>'//--></script>.
[/SIZE]
[SIZE=-1]
[/SIZE]
<!-- null -->
<table bgcolor="#e1e1e1" cellpadding="0" cellspacing="0" width="100%"> <tbody><tr><td align="left" bgcolor="#ffffff" valign="middle" width="5%">
</td> <th align="left" valign="middle" width="95%">[SIZE=+2] Abstract[/SIZE]</th></tr></tbody></table>
H5N1 influenza A viruses are exacting a growing human toll,<sup> </sup>with more than 240 fatal cases to date. In the event of an influenza<sup> </sup>pandemic by these viruses, embryonated chicken eggs, which are<sup> </sup>the approved substrate for human inactivated vaccine production,<sup> </sup>will likely be in short supply because chickens will be killed<sup> </sup>by these viruses or culled to limit the worldwide spread of<sup> </sup>the infection.
The Madin-Darby canine kidney (MDCK) cell line<sup> </sup>is a promising alternative candidate substrate because it supports<sup> </sup>efficient growth of influenza viruses compared to other cell<sup> </sup>lines.
Here, we addressed the molecular determinants for growth<sup> </sup>of an H5N1 vaccine seed virus in MDCK cells, revealing the critical<sup> </sup>responsibility of the Tyr residue at position 360 of PB2, the<sup> </sup>considerable requirement for functional balance between hemagglutinin<sup> </sup>(HA) and neuraminidase (NA), and the partial responsibility<sup> </sup>of the Glu residue at position 55 of NS1.
Based on these findings,<sup> </sup>we produced a PR8/H5N1 reassortant, optimized for this cell<sup> </sup>line, that derives all of its genes for its internal proteins<sup> </sup>from the PR8(UW) strain except for the NS gene, which derives<sup> </sup>from the PR8(Cambridge) strain, its N1 NA with a long stalk<sup> </sup>from an early H5N1 strain, and its HA with an avirulent-type<sup> </sup>cleavage site sequence derived from a circulating H5N1 virus.<sup>
</sup>
<sup> </sup>Our findings demonstrate the importance and feasibility of a<sup> </sup>cell-culture based approach to producing seed viruses for H5N1<sup> </sup>inactivated vaccines that grow robustly and in a timely, cost-efficient<sup> </sup>manner as an alternative to egg-based vaccine production.
http://kyxk.net/bbscon.php?board=Paper&id=11928&ap=278
<nobr>Shin Murakami,</nobr> <nobr>Taisuke Horimoto<sup>*</sup>,</nobr> <nobr>Le Quynh Mai,</nobr> <nobr>Chairul A. Nidom,</nobr> <nobr>Hualan Chen,</nobr> <nobr>Yukiko Muramoto,</nobr> <nobr>Shinya Yamada,</nobr> <nobr>Ayaka Iwasa,</nobr> <nobr>Kiyoko Iwatsuki-Horimoto,</nobr> <nobr>Masayuki Shimojima,</nobr> <nobr>Akira Iwata,</nobr> and <nobr>Yoshihiro Kawaoka<sup>*
</sup></nobr> Division of Virology, Department of Microbiology and Immunology, and International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama, Japan; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam, Avian Influenza Laboratory, Tropical Disease Centre, Airlangga University, Surabaya, Indonesia; Animal Influenza Laboratory of the Ministry of Agriculture and National Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, People's Republic of China; Nippon Institute for Biological Science, Tokyo, Japan; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin
[SIZE=-1] <sup>*</sup> To whom correspondence should be addressed. Email: horimoto@ims.u-tokyo.ac.jp<script type="text/javascript"><!-- var u = "horimoto", d = "ims.u-tokyo.ac.jp"; document.getElementById("em0").innerHTML = '<a href="mailto:' + u + '@' + d + '">' + u + '@' + d + '<\/a>'//--></script>. kawaoka@ims.u-tokyo.ac.jp<script type="text/javascript"><!-- var u = "kawaoka", d = "ims.u-tokyo.ac.jp"; document.getElementById("em1").innerHTML = '<a href="mailto:' + u + '@' + d + '">' + u + '@' + d + '<\/a>'//--></script>.
[/SIZE]
[SIZE=-1]
[/SIZE]
<!-- null -->
<table bgcolor="#e1e1e1" cellpadding="0" cellspacing="0" width="100%"> <tbody><tr><td align="left" bgcolor="#ffffff" valign="middle" width="5%">
H5N1 influenza A viruses are exacting a growing human toll,<sup> </sup>with more than 240 fatal cases to date. In the event of an influenza<sup> </sup>pandemic by these viruses, embryonated chicken eggs, which are<sup> </sup>the approved substrate for human inactivated vaccine production,<sup> </sup>will likely be in short supply because chickens will be killed<sup> </sup>by these viruses or culled to limit the worldwide spread of<sup> </sup>the infection.
The Madin-Darby canine kidney (MDCK) cell line<sup> </sup>is a promising alternative candidate substrate because it supports<sup> </sup>efficient growth of influenza viruses compared to other cell<sup> </sup>lines.
Here, we addressed the molecular determinants for growth<sup> </sup>of an H5N1 vaccine seed virus in MDCK cells, revealing the critical<sup> </sup>responsibility of the Tyr residue at position 360 of PB2, the<sup> </sup>considerable requirement for functional balance between hemagglutinin<sup> </sup>(HA) and neuraminidase (NA), and the partial responsibility<sup> </sup>of the Glu residue at position 55 of NS1.
Based on these findings,<sup> </sup>we produced a PR8/H5N1 reassortant, optimized for this cell<sup> </sup>line, that derives all of its genes for its internal proteins<sup> </sup>from the PR8(UW) strain except for the NS gene, which derives<sup> </sup>from the PR8(Cambridge) strain, its N1 NA with a long stalk<sup> </sup>from an early H5N1 strain, and its HA with an avirulent-type<sup> </sup>cleavage site sequence derived from a circulating H5N1 virus.<sup>
</sup>
<sup> </sup>Our findings demonstrate the importance and feasibility of a<sup> </sup>cell-culture based approach to producing seed viruses for H5N1<sup> </sup>inactivated vaccines that grow robustly and in a timely, cost-efficient<sup> </sup>manner as an alternative to egg-based vaccine production.
http://kyxk.net/bbscon.php?board=Paper&id=11928&ap=278